Platform for self-control in inflammatory bowel disease (EntrenaEII) (Q3175263): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): Platform for self-control in inflammatory bowel disease Development of a platform for patients with inflammatory bowel disease (EntrenaEII), which combines self-monitoring tools and treatment algorithms that allow self-control. EntrenaEII is made up of a control center and monitoring tools in the form of applications downloadable through the platform. The information obtained through monitoring is referred to the control center where it int...) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Platform for self-control in inflammatory bowel disease (EntrenaEII) | |||
Revision as of 18:11, 12 October 2021
Project Q3175263 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Platform for self-control in inflammatory bowel disease (EntrenaEII) |
Project Q3175263 in Spain |
Statements
48,800.0 Euro
0 references
61,000.0 Euro
0 references
80.0 percent
0 references
1 January 2016
0 references
31 March 2019
0 references
FUNDACION PROFESOR NOVOA SANTOS
0 references
43°29'4.88"N, 8°13'59.38"W
0 references
15036
0 references
Plataforma de autocontrol en enfermedad inflamatoria intestinal Desarrollo de una plataforma para pacientes con enfermedad inflamatoria intestinal (EntrenaEII), que reúna herramientas de automonitorización y algoritmos de tratamiento que permitan el autocontrol. EntrenaEII está formada por un centro de control y herramientas de monitorización en forma de aplicaciones descargables a través de la plataforma. La información obtenida con la monitorización, es derivada al centro de control donde se integra con los datos disponibles de la enfermedad, para generar de manera automatizada un plan de opciones terapéuticas y pautas de actuación. Esta herramienta informática permite el control y gestión del paciente con EII a distancia, evitando las consultas presenciales programadas y urgentes, así como las visitas al Servicio de Urgencias o ingresos innecesarios, ante un brote leve-moderado de la enfermedad. Con el empleo de la plataforma, el paciente participa activamente en su proceso aumentando su capacidad para el auto-tratamiento, incrementando la adherencia al mismo y consiguiendo un mejor control evolutivo de su enfermedad. Tras el desarrollo de la plataforma, se realizará una evaluación entre los pacientes de las Unidades participantes para analizar su aceptación y definir el perfil de paciente más apropiado para su utilización. Esta evaluación ayudará a determinar la utilidad y aplicabilidad de EntrenaEII como posible estrategia futura de asistencia telemática en pacientes con EII. (Spanish)
0 references
Platform for self-control in inflammatory bowel disease Development of a platform for patients with inflammatory bowel disease (EntrenaEII), which combines self-monitoring tools and treatment algorithms that allow self-control. EntrenaEII is made up of a control center and monitoring tools in the form of applications downloadable through the platform. The information obtained through monitoring is referred to the control center where it integrates with the available data of the disease, in order to generate in an automated way a plan of therapeutic options and action guidelines. This IT tool allows the control and management of patients with IBD remotely, avoiding scheduled and urgent face-to-face consultations, as well as visits to the Emergency Service or unnecessary income, in the face of a mild-moderate outbreak of the disease. With the use of the platform, the patient actively participates in its process by increasing its capacity for self-treatment, increasing adherence to it and achieving better evolutionary control of its disease. After the development of the platform, an evaluation will be carried out among the patients of the participating Units to analyse its acceptance and define the patient profile most appropriate for its use. This evaluation will help determine the usefulness and applicability of EntrenaEII as a possible future strategy for telematics care in patients with IBD. (English)
12 October 2021
0 references
Ferrol
0 references
Identifiers
DTS15_00113
0 references